<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags:  t cells</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with ' t cells'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22+t+cells%22&t=%22+t+cells%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:26:55 +0100</lastBuildDate>
        <item>
            <title>Penn’s Genetically Modified T Cells Create Antitumor Effect In Mice With Folate Positive Ovarian Cancer; Clinical Trial Pending</title>
            <link>http://www.medworm.com/index.php?rid=5140183&amp;cid=t_449914_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2011%2F08%2F17%2Fpenns-genetically-modified-t-cells-create-antitumor-effect-in-mice-with-folate-positive-ovarian-cancer-clinical-trial-pending%2F</link>
            <description>In a recent issue of Cancer Research, researchers from the University of Pennsylvania showed for the first time that engineered human T cells can eradicate deadly human ovarian cancer in immune-deficient mice. A clinical trial involving the modified T cells is expected to be announced within the next few months. In a recent issue of Cancer Research, Daniel [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5140183</comments>
            <pubDate>Wed, 17 Aug 2011 22:50:23 +0100</pubDate>
            <guid isPermaLink="false">5140183</guid>        </item>
        <item>
            <title>TWiV 82: Immunology in silico</title>
            <link>http://www.medworm.com/index.php?rid=3569654&amp;cid=t_449914_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fmedia.rawvoice.com%2Fpmn_twiv%2Fwww.twiv.tv%2FTWiV082.mp3</link>
            <description>Hosts: Vincent Racaniello and Rich Condit
On episode #82 of the podcast This Week in Virology (TWiV), Vincent and Rich talk about how thymic selection of T cells might lead to better control of HIV-1 infection, and a mouse model for severe antibody-induced dengue virus disease.
This episode is sponsored by Data Robotics Inc. Use the promotion code TWIVPOD to receive $75-$500 off a Drobo.
Win a free Drobo S! Contest rules here.
Download TWiV #82 (59 MB .mp3, 82 minutes)
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, or by email, or listen on your mobile device with Stitcher Radio.
Links for this episode:

Effect of thymic selection of T-cells on control of AIDS
Mouse model of antibody-induced severe dengue virus disease
Natural antibody protects against viral...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3569654</comments>
            <pubDate>Sun, 16 May 2010 22:05:28 +0100</pubDate>
            <guid isPermaLink="false">3569654</guid>        </item>
        <item>
            <title>Will NIH Urge New HIV Guidelines Boosting Meds?</title>
            <link>http://www.medworm.com/index.php?rid=1915065&amp;cid=t_449914_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F434035028%2F</link>
            <description>A new government-funded study suggests that patients with HIV may have less risk of dying if they begin HAART, or highly active antiretroviral therapy, sooner than current guidelines currently recommend. The existing treatment guidelines call for meds to be considered when CD4+ T-cell counts fall below 350 cells per cubic millimeter. 
HIV, you may recall, ravages CD4+ T-cells, which fight off infection, but as virus levels increase, a decrease in CD4+ T-cells occurs. The HAART regimen, which combines at least three HIV meds, is used to reduce virus levels. However, the ideal time to start treatment therapy has been unclear because of insufficient clinical trial data. 
And so researchers worked with the International Epidemiology Databases to Evaluate AIDS (IeDEA), which is a global network...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1915065</comments>
            <pubDate>Tue, 28 Oct 2008 04:05:26 +0100</pubDate>
            <guid isPermaLink="false">1915065</guid>        </item>
        <item>
            <title>New nano device detects immune system cell signaling</title>
            <link>http://www.medworm.com/index.php?rid=2382514&amp;cid=t_449914_107_f&amp;fid=38577&amp;url=http%3A%2F%2Fbiosingularity.wordpress.com%2F2008%2F09%2F04%2Fnew-nano-device-detects-immune-system-cell-signaling%2F</link>
            <description>Scientists have detected previously unnoticed chemical signals that individual cells in the immune system use to communicate with each other over short distances.
The signals the researchers detected originated in dendritic cells – the sentinels of the immune system that do the initial detection of microscopic invaders – and were received by nearby T-cells, which play [...] (Source: Biosingularity)</description>
            <author>Biosingularity</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2382514</comments>
            <pubDate>Thu, 04 Sep 2008 16:14:38 +0100</pubDate>
            <guid isPermaLink="false">2382514</guid>        </item>
        <item>
            <title>New study looks at B-cell activity for MS</title>
            <link>http://www.medworm.com/index.php?rid=1239384&amp;cid=t_449914_129_f&amp;fid=36038&amp;url=http%3A%2F%2Fblog.healthtalk.com%2Fmultiple-sclerosis%2Flife-with-ms%2Fnew-study-looks-at-b-cell-activity-for-ms%2F</link>
            <description>For the longest time, it seems that the immune cells we’ve been hearing about have been the T-Cells, known also as Thymus Lymphocytes (because the Thymus seems to be principally involved in their development). It has been long thought that these T-Cells are the primary culprit in demyelinization, being that T-Cells are in charge of “cell-mediated” immune response.
Well, “we” might have thought that, but an ever larger group of researchers have been talking about the B-Cells. These cells are primary to humoral immune response, which has to do with secreted antibodies, as opposed to doing the actual immune work themselves.
A study released last week by researchers at UCSF finds that these B-Cells may also have a hand in the destruction of our nervous system. Not the only hand, but ...</description>
            <author>Life with MS</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1239384</comments>
            <pubDate>Mon, 18 Feb 2008 20:48:43 +0100</pubDate>
            <guid isPermaLink="false">1239384</guid>        </item>
        <item>
            <title>History underway in type 1 diabetes cure</title>
            <link>http://www.medworm.com/index.php?rid=747149&amp;cid=t_449914_87_f&amp;fid=34867&amp;url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F07%2F20%2Fhistory-underway-in-type-1-diabetes-cure%2F</link>
            <description>Filed under: Type 1, Childhood, Research, Events, SupportDr. Faustman's lab is currently collecting blood samples from individuals with established Type 1 diabetes. These samples are being used to quantify the number of autoreactive T-cells and develop the adequate dosage for Phase 1 of human trials to cure Type 1 diabetes.
The research has been presented and the NIH confirmed it. By reeducating the confused T-cells and instructing them not to attack healthy islets, an apparent cure of established type 1 diabetes in non-obese diabetic mice is possible. Now, Dr. Faustman is collecting human samples to bestow the same cure for diabetes in humans. 
If you wish to be a part of this revolutionary event for curing Type 1 diabetes, please contact the Clinical Coordinator or call Dr. Faustman's la...</description>
            <author>The Diabetes Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=747149</comments>
            <pubDate>Fri, 20 Jul 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">747149</guid>        </item>
        <item>
            <title>Training immune system to kill nasopharyngeal cancer</title>
            <link>http://www.medworm.com/index.php?rid=690000&amp;cid=t_449914_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F06%2F22%2Ftraining-immune-system-to-kill-nasopharyngeal-cancer%2F</link>
            <description>Filed under: Throat Cancer, Clinical Trials, Research, Diets, Head and Neck cancerNasopharyngeal cancer is most prevalent in South China and kills one in every three victims. The disease is thought to be linked to diets rich in preserved foods, like salted fish.
Scientists will soon test an experimental treatment for nose and throat cancer that will train the patient's own white blood cells to fight the disease. Some classes of T-cells have memory. Once these cells are taken from the patient and are exposed to invaders that they successfully fought off, they should launch the same response when they are re-introduced back into the patients own body.
One of the researchers stated &quot;We expect the T-cells to initiate a very aggressive inflammatory reaction and during the process, not only will...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=690000</comments>
            <pubDate>Fri, 22 Jun 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">690000</guid>        </item>
        <item>
            <title>Type 1 vaccination successfully tested on mice</title>
            <link>http://www.medworm.com/index.php?rid=644949&amp;cid=t_449914_87_f&amp;fid=34867&amp;url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F05%2F30%2Ftype-1-vaccination-successfully-tested-on-mice%2F</link>
            <description>Filed under: Type 1, ResearchI do not like vaccinations. I wonder if they are connected to the autism and diabetes epidemics, even attention-deficit disorders. I do vaccinate my children, just begrudgingly. Yet if there ever was a vaccination against type 1 diabetes, I would be first in line. 
Researchers in France and Germany have demonstrated you can treat a type 1 diabetic mouse with a vaccination. Type 1 diabetes is an autoimmune disease in which the immune system's T cells cannot distinguish between &quot;non-self&quot; and &quot;self&quot;, attacking cells of the pancreas that produce insulin. 
Previously, Drs. Falk and Rotzschke of the Max Delbruck Center for Molecular Medicine (MDC), blocked the misdirected immune system by vaccinating mice with modified structures of the same organ targeted by the de...</description>
            <author>The Diabetes Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=644949</comments>
            <pubDate>Wed, 30 May 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">644949</guid>        </item>
    </channel>
</rss>

